DIGEST Clinical Trials

109 recruitingLast updated: July 25, 2026

There are 109 actively recruiting digest clinical trials across 44 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Houston, Texas, United States, Dijon, France, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


DIGEST Trials at a Glance

109 actively recruiting trials for digest are listed on ClinicalTrialsFinder across 6 cities in 44 countries. The largest study group is Not Applicable with 42 trials, with the heaviest enrollment activity in Houston, Dijon, and Beijing. Lead sponsors running digest studies include Mayo Clinic, M.D. Anderson Cancer Center, and Beijing Tiantan Hospital.

Treatments under study

About DIGEST Clinical Trials

Looking for clinical trials for DIGEST? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new DIGEST trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about DIGEST clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 109 trials

Recruiting

Changes in Ciprofol Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia

InsomniaDigestive Endoscopy
Beijing Tiantan Hospital840 enrolled1 locationNCT06897007
Recruiting

Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia

InsomniaDigestive Endoscopy
Beijing Tiantan Hospital840 enrolled1 locationNCT07028190
Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled285 locationsNCT07222800
Recruiting

Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia

InsomniaDigestive Endoscopy
Beijing Tiantan Hospital840 enrolled1 locationNCT07028177
Recruiting
Phase 2

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Unresectable Digestive System Neuroendocrine Tumor G1Unresectable Digestive System Neuroendocrine Tumor G2Metastatic Digestive System Neuroendocrine Tumor G1+1 more
National Cancer Institute (NCI)100 enrolled39 locationsNCT05773274
Recruiting

Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers

Malignant Digestive System Neoplasm
M.D. Anderson Cancer Center150 enrolled1 locationNCT04629677
Recruiting

Product Surveillance Registry

Cardiac Rhythm DisordersDigestive disordersMinimally Invasive Surgical Procedures+13 more
Medtronic100,000 enrolled400 locationsNCT01524276
Recruiting
Not Applicable

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Dartmouth-Hitchcock Medical Center8,946 enrolled22 locationsNCT05612347
Recruiting
Not Applicable

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Esophageal CarcinomaGastric CarcinomaGastroesophageal Junction Carcinoma+7 more
Alliance for Clinical Trials in Oncology420 enrolled344 locationsNCT07283939
Recruiting
Phase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+7 more
NRG Oncology269 enrolled270 locationsNCT06500455
Recruiting
Phase 4

Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors

Metastatic Malignant Neoplasm in the LiverDigestive System Neuroendocrine Tumor G1Digestive System Neuroendocrine Tumor G2+3 more
Vanderbilt-Ingram Cancer Center6 enrolled1 locationNCT06016855
Recruiting
Not Applicable

Intestinal Organoids

Crohn DiseaseDigestive System DiseasesInflammatory Bowel Disease, Ulcerative Colitis Type
Rennes University Hospital90 enrolled1 locationNCT05294107
Recruiting
Not Applicable

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Urothelial CarcinomaCervical CarcinomaCutaneous Melanoma+7 more
Institut Claudius Regaud450 enrolled1 locationNCT06967961
Recruiting

An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy

Digestive System Malignancies
Tianjin Medical University Cancer Institute and Hospital90 enrolled1 locationNCT07263620
Recruiting
Not Applicable

Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections

Postoperative ComplicationsAnastomotic LeaksAnastomotic Complication+8 more
Medtronic - MITG137 enrolled9 locationsNCT07351071
Recruiting

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Breast CarcinomaEsophageal CarcinomaHead and Neck Carcinoma+6 more
M.D. Anderson Cancer Center5,000 enrolled1 locationNCT00991094
Recruiting
Phase 3

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Colorectal NeoplasmsNeoplasm MetastasisGastrointestinal Neoplasms+2 more
Sun Yat-sen University280 enrolled1 locationNCT03303495
Recruiting
Phase 1Phase 2

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Malignant Digestive System Neoplasm
Mayo Clinic60 enrolled1 locationNCT07456852
Recruiting
Phase 2

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Malignant Solid NeoplasmLung Neuroendocrine NeoplasmDigestive System Neuroendocrine Neoplasm+1 more
Roswell Park Cancer Institute60 enrolled1 locationNCT06202066
Recruiting
Not Applicable

Organoid Models of Hepatocellular Carcinoma

SurgeryHepatocellular CarcinomaOrganoids+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS150 enrolled1 locationNCT06929845